Assessment of Myocardial Tissue Damage in Aortic Stenosis

Assessment of Myocardial Tissue Damage in Aortic Stenosis for Risk Stratification

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02101619

Enrollment

Registered

2014-04-02

Start date

2013-08-31

Completion date

2016-06-30

Last updated

2016-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Stenosis

Keywords

aortic stenosis, myocardial tissue, echocardiography, MRI

Brief summary

Aortic stenosis (AS) is the most common valve disease in the United States and most common indication for valve replacement surgery. Anatomical and hemodynamic severity of AS is insufficient for elucidating patients' prognosis. Therefore, the decision about the optimal timing of surgical intervention remains critical. However, the changes in structure and electrical activity of the cardiac muscle can be assessed by noninvasive imaging and electrocardiography (ECG). Degenerative myocardial changes characterized by fibrosis or collagen deposits are frequently observed in AS patients and have a negative impact on patient outcomes. In this project, our objective is to determine whether echocardiographic image analysis of integrated backscatter (IB), which can express changes in myocardial tissue composition (amount of fibrosis) based on its ultrasound reflectivity, global left ventricular (LV) load as measured by Zva, and ECG analysis of the duration of the QRS interval have a role in risk stratification for AS patients and to apply those methods to identify which patients would benefit from surgical intervention. The investigators hypothesize that 1) the severity of myocardial damage can discriminate the prognosis in patients with AS, and 2) IB, Zva, and QRS interval can be diagnostic measures of the severity of myocardial damage. The investigators will measure the severity of myocardial fibrosis using MRI (reference) in 50 patients and will test the diagnostic significance of IB (testing method). Zva, QRS duration, and conventional echocardiographic measures will also be tested for diagnosing severity of myocardial fibrosis.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

Inclusion criteria

* Moderate or severe aortic stenosis determined by echocardiography * Adults \> 65 years old

Exclusion criteria

* Ejection fraction \< 50% * Valvular diseases of more than or equal to moderate degree other than aortic stenosis * Prior myocardial infarction or coronary artery disease needs revascularization * Atrial fibrillation (chronic) * Pacemaker/defibrillator implanted * Previous valve replacement performed * Cardiomyopathy(HCM, infiltrative cardiomyopathy, constriction) * Renal dysfunction (estimated GFR \< 30ml/min/1.73m² or end stage renal failure) * Patients with contraindication for MRI * Patients with poor echocardiographic images

Design outcomes

Primary

Measure	Time frame
Presence of myocardial fibrotic change determined by MRI.	1 hour

Countries

United States

Outcome results